Department of Pharmacy, Laboratory of Metabolomics and Drug-Induced Liver Injury, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
J Proteome Res. 2023 Jul 7;22(7):2327-2338. doi: 10.1021/acs.jproteome.3c00093. Epub 2023 May 26.
Incidence and mortality rates of alcoholic liver disease (ALD) is one of the highest in the world. In the present study, we found that the genetic knockout nuclear receptor the peroxisome proliferator-activated receptor α (PPARα) exacerbated ALD. Lipidomics of the liver revealed changed levels of lipid species encompassing phospholipids, ceramides (CM), and long-chain fatty acids in -null mice induced by ethanol. Moreover, 4-hydroxyphenylacetic acid (4-HPA) was changed as induced by ethanol in the metabolome of urine. Moreover, the phylum level analysis showed a decrease in the level of Bacteroidetes and an increase in the level of Firmicutes after alcohol feeding in -null mice, while there was no change in wild-type mice. In -null mice, the level of and were upregulated after alcohol feeding. These data revealed that PPARα deficiency potentiated alcohol-induced liver injury through promotion of lipid accumulation, changing the metabolome of urine, and increasing the level of and . 4-HPA could improve ALD in mice by regulating inflammation and lipid metabolism. Therefore, our findings suggest a novel approach to the treatment of ALD: focusing on the gut microbiota and its metabolites. Data are available via ProteomeXchange (PXD 041465).
酒精性肝病 (ALD) 的发病率和死亡率是世界上最高的之一。在本研究中,我们发现过氧化物酶体增殖物激活受体 α (PPARα) 的基因敲除核受体使 ALD 恶化。肝脏脂质组学显示,乙醇诱导的 -null 小鼠中包含磷脂、神经酰胺 (CM) 和长链脂肪酸在内的脂质种类水平发生变化。此外,尿液代谢组学中发现 4-羟苯乙酸 (4-HPA) 也因乙醇而发生变化。此外,门水平分析显示,在 -null 小鼠中,酒精喂养后拟杆菌门的水平下降,厚壁菌门的水平升高,而在野生型小鼠中没有变化。在 -null 小鼠中,酒精喂养后 和 的水平上调。这些数据表明,PPARα 缺乏通过促进脂质积累、改变尿液代谢组学以及增加 和 的水平,加剧了酒精引起的肝损伤。4-HPA 可以通过调节炎症和脂质代谢来改善小鼠的 ALD。因此,我们的研究结果表明,一种治疗 ALD 的新方法是关注肠道微生物群及其代谢物。数据可通过 ProteomeXchange (PXD 041465) 获取。